Quince Therapeutics
QNCX
#8241
Rank
โ‚ฌ0.20 B
Marketcap
3,75ย โ‚ฌ
Share price
10.28%
Change (1 day)
92.11%
Change (1 year)

Earnings for Quince Therapeutics (QNCX)

Earnings in 2025 (TTM): -โ‚ฌ37.74 Million

According to Quince Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ30.82 Million a decrease over its 2023 earnings that were of -โ‚ฌ23.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quince Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ37.74 Million22.47%
2024 -โ‚ฌ30.82 Million33.58%
2023 -โ‚ฌ23.07 Million-47.15%
2022 -โ‚ฌ43.65 Million-43.27%
2021 -โ‚ฌ76.95 Million17.53%
2020 -โ‚ฌ65.47 Million99.1%
2019 -โ‚ฌ32.89 Million235.08%
2018 -โ‚ฌ9.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.13 Billion 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA